U.S. Markets open in 84 hrs, 6 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,543.55 | -171.63 | -1.47% |
| NASDAQ | 2,367.52 | -44.12 | -1.83% |
| S&P 500 | 1,282.83 | -17.85 | -1.37% |
| Day Low 10:14 AM EDT | 0.179 | |
|---|---|---|
| Day High 09:35 AM EDT | 0.225 |
|
| Range | 0.05 | |
| Volume | 5.57 M | |
| 30-Day Avg. Vol. | 1.15 M |
|
| Difference | 381.48% | |
| Market Cap. | 15.94 M | |
| Change | -1.58 M | |
| Shares Out. | 83.62 M | |
| Percent Traded | 6.64% | |
| Revenue | 1.27 M | |
| Earnings | -8.78 M | |
| EPS (TTM) | -0.10 |
| 52-Wk Low 10:14 AM EDT | 0.179 | |
|---|---|---|
| 52-Wk High 2/4/08 | 1.75 |
|
| Range | 1.57 | |
| Prev. Close 8/28/08 | 0.2089 | |
| Today's Open | 0.21 | |
| Change | 0.53% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.8461 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
NexMed wants you to rub it in. The drug development company uses its NexACT technology to deliver drugs through the skin; it is developing topical formulations with improved absorption rates, using already-proven ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.03 3/31/08 | -0.02 3/31/08 |
0.01
Beat
|
| Last Quarter | -0.02 6/30/08 | -0.02 6/30/08 |
0.00
Met
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 1.20 M | 1.27 M |
| Gross Profit | 115,161.00 | 648,498.00 |
| Operating Income | -1.09 M | -9.38 M |
| Net Income | -1.63 M | -8.79 M |
Real-Time Quote
